Adagio Medical (Nasdaq:ADGM) announced today that it received FDA investigational device exemption (IDE) to expand its ...

Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (“Adagio” or “the Company”), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced that the U.S.

- Atrial Fibrillation (AF): A common supraventricular arrhythmia associated with a significantly increased risk of stroke- Ventricular Tachycardia (VT): A potentially fatal ventricular arrhythmia, for ...

Johns Hopkins researchers built a virtual replica of each patient’s heart, simulated the electrical circuits causing a ...

Researchers at Johns Hopkins Medicine built a virtual replica of a patient’s heart, ran electrical simulations through it, ...

“For patients, digital twins can be life-changing and life-saving,” said first author Jonathan Chrispin, a cardiologist who specializes in treating arrythmias. “We show we can make their procedures ...

Working with "digital twins" of patients' hearts, doctors improved cardiac ablation outcomes for patients with ...

Working with "digital twins" of patients' hearts, doctors have improved cardiac ablation outcomes for patients with ...

Scientists at Johns Hopkins University are creating virtual replicas of patients’ hearts so they can test how to fix a ...

The study, titled “Artificial Intelligence ECG Localization Facilitates Focused Activation Mapping and Improves Outcomes in Hemodynamically Unstable Ventricular Tachycardia,” demonstrated that 80% of ...

New Adagio Medical Publication Highlights Consistent Safety and Effectiveness with Ultralow Temperature Ablation in Broad Range of Patients with Ventricular Tachycardia Early Feasibility Outcomes in a ...

Ventricular tachycardia (VT) remains a leading cause of sudden cardiac death, even in the era of implantable defibrillators and catheter ablation. Drawing on his own experimental and clinical research ...